Literature DB >> 14528906

The human pituitary proteome: the characterization of differentially expressed proteins in an adenoma compared to a control.

D M Desiderio1, X Zhan.   

Abstract

In order to clarify the basic molecular mechanisms that participate in the formation of human pituitary macroadenomas, this study, for the first time, describes the comparative proteomics between a pituitary adenoma tissue and a control tissue. A vertical, two-dimensional polyacrylamide gel electrophoresis system and PDQuest image analysis software were used to provide a high level of between-gel reproducibility and electrophoretic separation to accurately locate each differentially expressed protein. Mass spectrometry (MALDI-TOF and LC-ESI-Q-IT) and protein databases were used to characterize each differentially expressed protein. A total of 137 differential gel spots (37 increased spot volumes, 39 decreased, 19 new and 42 lost) were found when we compared an adenoma proteome to a control proteome. Seventy-one spots (20 increased, 27 decreased, 13 new, 11 lost), representing 39 differentially regulated proteins, were identified. Five differentially regulated proteins (prolactin, cellular retinoic acid-binding protein II, G-protein beta subunit 3, secretagogin and calreticulin) were also validated with results from a comparative transcriptomics study of pituitary adenomas and controls. The functional characteristics of these differentially expressed proteins provide a differential proteomic profile between a pituitary adenoma and a control.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14528906

Source DB:  PubMed          Journal:  Cell Mol Biol (Noisy-le-grand)        ISSN: 0145-5680            Impact factor:   1.770


  9 in total

1.  Two-dimensional Gel Electrophoresis Coupled with Mass Spectrometry Methods for an Analysis of Human Pituitary Adenoma Tissue Proteome.

Authors:  Xianquan Zhan; Yuda Huang; Ying Long
Journal:  J Vis Exp       Date:  2018-04-02       Impact factor: 1.355

2.  In vitro and in vivo protein-bound tyrosine nitration characterized by diagonal chromatography.

Authors:  Bart Ghesquière; Niklaas Colaert; Kenny Helsens; Lien Dejager; Caroline Vanhaute; Katleen Verleysen; Koen Kas; Evy Timmerman; Marc Goethals; Claude Libert; Joël Vandekerckhove; Kris Gevaert
Journal:  Mol Cell Proteomics       Date:  2009-09-09       Impact factor: 5.911

3.  Proteomic analysis of prolactinoma cells by immuno-laser capture microdissection combined with online two-dimensional nano-scale liquid chromatography/mass spectrometry.

Authors:  Yingchao Liu; Jinsong Wu; Guoquan Yan; Ruiping Hou; Dongxiao Zhuang; Luping Chen; Qi Pang; Jianhong Zhu
Journal:  Proteome Sci       Date:  2010-01-29       Impact factor: 2.480

4.  Proteomics and transcriptomics analyses of secretagogin down-regulation in human non-functional pituitary adenomas.

Authors:  Xianquan Zhan; Chheng-Orn Evans; Nelson M Oyesiku; Dominic M Desiderio
Journal:  Pituitary       Date:  2003       Impact factor: 4.107

Review 5.  The renaissance of Ca2+-binding proteins in the nervous system: secretagogin takes center stage.

Authors:  Alán Alpár; Johannes Attems; Jan Mulder; Tomas Hökfelt; Tibor Harkany
Journal:  Cell Signal       Date:  2011-10-01       Impact factor: 4.315

Review 6.  Prognostic indicators in pituitary tumors.

Authors:  Agustinus Suhardja; Kalman Kovacs; Oded Greenberg; Bernd W Scheithauer; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2005       Impact factor: 4.056

7.  Overexpression of the Notch3 receptor and its ligand Jagged1 in human clinically non-functioning pituitary adenomas.

Authors:  Runchun Lu; Hua Gao; Hongyun Wang; Lei Cao; Jiwei Bai; Yazhuo Zhang
Journal:  Oncol Lett       Date:  2013-01-07       Impact factor: 2.967

8.  Multi-parameter systematic strategies for predictive, preventive and personalised medicine in cancer.

Authors:  Rong Hu; Xiaowei Wang; Xianquan Zhan
Journal:  EPMA J       Date:  2013-01-22       Impact factor: 6.543

Review 9.  Genomic and oncoproteomic advances in detection and treatment of colorectal cancer.

Authors:  Seamus M McHugh; Jill O'Donnell; Peter Gillen
Journal:  World J Surg Oncol       Date:  2009-04-01       Impact factor: 2.754

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.